ArticleCancer discovery2025

Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non-Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy.

Simon Baldacci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.